JEAN JACQUES BIENAIME Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEAN JACQUES BIENAIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEAN JACQUES BIENAIME. JEAN JACQUES BIENAIME is Director in INCYTE CORP ($INCY) and Chief Executive Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in VITAL THERAPIES INC ($VTL).
Latest Insider Trading Transactions of JEAN JACQUES BIENAIME
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BMRN, VTL, INCY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 37.46 | 1,000 | 37,460 | 138,000 | |
| Jun 23 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 37.46 | 1,000 | 37,460 | 304,839 | 303.8 K to 304.8 K (+0.33 %) |
| May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,513 | 225,509 | 0 | |
| May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.29 | 8,513 | 657,970 | 303,839 | 312.4 K to 303.8 K (-2.73 %) |
| May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,513 | 225,509 | 312,352 | 303.8 K to 312.4 K (+2.80 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 25,000 | 662,250 | 8,513 | |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 25,000 | 662,250 | 33,513 | |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 79.39 | 3,329 | 264,303 | 303,839 | 307.2 K to 303.8 K (-1.08 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.77 | 6,115 | 481,672 | 307,168 | 313.3 K to 307.2 K (-1.95 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.60 | 15,556 | 1,207,146 | 313,283 | 328.8 K to 313.3 K (-4.73 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 25,000 | 662,250 | 328,839 | 303.8 K to 328.8 K (+8.23 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.69 | 10,175 | 800,671 | 303,839 | 314 K to 303.8 K (-3.24 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.01 | 14,825 | 1,156,528 | 314,014 | 328.8 K to 314 K (-4.51 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 25,000 | 662,250 | 328,839 | 303.8 K to 328.8 K (+8.23 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 62.41 | 341 | 21,281 | 303,839 | 303.5 K to 303.8 K (+0.11 %) |
| May 03 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 37.46 | 1,000 | 37,460 | 139,000 | |
| May 03 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 37.46 | 1,000 | 37,460 | 303,498 | 302.5 K to 303.5 K (+0.33 %) |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 10,000 | 264,900 | 58,513 | |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 10,000 | 264,900 | 68,513 | |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 10,000 | 264,900 | 58,513 | |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 79.34 | 10,000 | 793,400 | 302,498 | 312.5 K to 302.5 K (-3.20 %) |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 10,000 | 264,900 | 68,513 | |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 10,000 | 264,900 | 312,498 | 302.5 K to 312.5 K (+3.31 %) |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 79.34 | 10,000 | 793,400 | 302,498 | 312.5 K to 302.5 K (-3.20 %) |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.91 | 10,000 | 789,100 | 302,498 | 312.5 K to 302.5 K (-3.20 %) |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 10,000 | 264,900 | 312,498 | 302.5 K to 312.5 K (+3.31 %) |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 10,000 | 264,900 | 312,498 | 302.5 K to 312.5 K (+3.31 %) |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.91 | 10,000 | 789,100 | 302,498 | 312.5 K to 302.5 K (-3.20 %) |
| Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 10,000 | 264,900 | 312,498 | 302.5 K to 312.5 K (+3.31 %) |
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 78.52 | 5,519 | 433,352 | 302,498 | 308 K to 302.5 K (-1.79 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 78.39 | 101,820 | 7,981,670 | 101,820 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 77.21 | 5,559 | 429,210 | 308,017 | 313.6 K to 308 K (-1.77 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 78.39 | 23,426 | 1,836,364 | 313,576 | 337 K to 313.6 K (-6.95 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 41,350 | 0 | 337,002 | 295.7 K to 337 K (+13.99 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 7,000 | 185,430 | 78,513 | |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 7,000 | 185,430 | 85,513 | |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.10 | 7,000 | 539,700 | 295,652 | 302.7 K to 295.7 K (-2.31 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 7,000 | 185,430 | 302,652 | 295.7 K to 302.7 K (+2.37 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.68 | 7,000 | 543,760 | 295,652 | 302.7 K to 295.7 K (-2.31 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 7,000 | 185,430 | 302,652 | 295.7 K to 302.7 K (+2.37 %) |
| Mar 15 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | L | 77.94 | 100 | 7,794 | 295,652 | 295.6 K to 295.7 K (+0.03 %) |
| Feb 22 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 7,000 | 185,430 | 92,513 | |
| Feb 22 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.58 | 7,000 | 585,060 | 295,552 | 302.6 K to 295.6 K (-2.31 %) |
| Feb 22 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 7,000 | 185,430 | 302,552 | 295.6 K to 302.6 K (+2.37 %) |
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 7,000 | 185,430 | 99,513 | |
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 85.08 | 7,000 | 595,560 | 295,552 | 302.6 K to 295.6 K (-2.31 %) |
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 7,000 | 185,430 | 302,552 | 295.6 K to 302.6 K (+2.37 %) |
| Feb 18 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,000 | 211,920 | 106,513 | |
| Feb 18 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.54 | 8,000 | 676,320 | 295,552 | 303.6 K to 295.6 K (-2.64 %) |
| Feb 18 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,000 | 211,920 | 303,552 | 295.6 K to 303.6 K (+2.71 %) |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,334 | 220,768 | 114,513 | |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,333 | 220,741 | 122,847 | |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.67 | 8,334 | 688,972 | 295,552 | 303.9 K to 295.6 K (-2.74 %) |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,334 | 220,768 | 303,886 | 295.6 K to 303.9 K (+2.82 %) |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.91 | 8,333 | 690,889 | 295,552 | 303.9 K to 295.6 K (-2.74 %) |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,333 | 220,741 | 303,885 | 295.6 K to 303.9 K (+2.82 %) |
| Jan 28 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,333 | 220,741 | 131,180 | |
| Jan 28 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 85.49 | 8,333 | 712,388 | 295,552 | 303.9 K to 295.6 K (-2.74 %) |
| Jan 28 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,333 | 220,741 | 303,885 | 295.6 K to 303.9 K (+2.82 %) |
| Jan 05 2021 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 86.98 | 275 | 23,920 | 8,921 | 8.6 K to 8.9 K (+3.18 %) |
| Jan 05 2021 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 86.98 | 275 | 23,920 | 8,921 | 8.6 K to 8.9 K (+3.18 %) |
| Dec 30 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.18 | 1,500 | 132,270 | 295,552 | 297.1 K to 295.6 K (-0.50 %) |
| Dec 30 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.77 | 1,500 | 133,155 | 297,052 | 298.6 K to 297.1 K (-0.50 %) |
| Dec 30 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 425 | 0 | 247,533 | 248 K to 247.5 K (-0.17 %) |
| Nov 12 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | S | 83.00 | 798 | 66,234 | 8,646 | 9.4 K to 8.6 K (-8.45 %) |
| Nov 12 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | S | 83.00 | 798 | 66,234 | 8,646 | 9.4 K to 8.6 K (-8.45 %) |
| Oct 01 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 89.74 | 254 | 22,794 | 9,444 | 9.2 K to 9.4 K (+2.76 %) |
| Jul 01 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 103.97 | 208 | 21,626 | 9,190 | 9 K to 9.2 K (+2.32 %) |
| May 28 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
| May 28 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 0.00 | 1,282 | 0 | 8,982 | 7.7 K to 9 K (+16.65 %) |
| May 12 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 20,000 | 430,200 | 0 | |
| May 12 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.72 | 20,000 | 1,834,400 | 298,552 | 318.6 K to 298.6 K (-6.28 %) |
| May 12 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 20,000 | 430,200 | 318,552 | 298.6 K to 318.6 K (+6.70 %) |
| May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 5,000 | 107,550 | 20,000 | |
| May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 4,000 | 86,040 | 25,000 | |
| May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.00 | 5,000 | 440,000 | 298,552 | 303.6 K to 298.6 K (-1.65 %) |
| May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 5,000 | 107,550 | 303,552 | 298.6 K to 303.6 K (+1.67 %) |
| May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.38 | 4,000 | 357,520 | 298,552 | 302.6 K to 298.6 K (-1.32 %) |
| May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 4,000 | 86,040 | 302,552 | 298.6 K to 302.6 K (+1.34 %) |
| May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 62.59 | 339 | 21,217 | 298,552 | 298.2 K to 298.6 K (+0.11 %) |
| Apr 29 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 20,000 | 430,200 | 29,000 | |
| Apr 29 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 20,000 | 430,200 | 49,000 | |
| Apr 29 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 97.58 | 20,000 | 1,951,600 | 298,213 | 318.2 K to 298.2 K (-6.29 %) |
| Apr 29 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 20,000 | 430,200 | 318,213 | 298.2 K to 318.2 K (+6.71 %) |
| Apr 29 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 97.73 | 20,000 | 1,954,600 | 298,213 | 318.2 K to 298.2 K (-6.29 %) |
| Apr 29 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 20,000 | 430,200 | 318,213 | 298.2 K to 318.2 K (+6.71 %) |
| Apr 13 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 10,000 | 215,100 | 69,000 | |
| Apr 13 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 79.06 | 10,000 | 790,600 | 298,213 | 308.2 K to 298.2 K (-3.24 %) |
| Apr 13 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 10,000 | 215,100 | 308,213 | 298.2 K to 308.2 K (+3.35 %) |
| Apr 08 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 1,000 | 26,490 | 139,513 | |
| Apr 08 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 1,000 | 26,490 | 298,213 | 297.2 K to 298.2 K (+0.34 %) |
| Apr 08 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 1,000 | 26,490 | 139,513 | |
| Apr 08 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 1,000 | 26,490 | 298,213 | 297.2 K to 298.2 K (+0.34 %) |
| Mar 24 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 73.05 | 13,128 | 959,000 | 297,213 | 310.3 K to 297.2 K (-4.23 %) |
| Mar 17 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 73.82 | 127,920 | 9,443,054 | 127,920 | |
| Mar 17 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 44,850 | 0 | 310,341 | 265.5 K to 310.3 K (+16.89 %) |
| Mar 17 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 84.50 | 30,952 | 2,615,444 | 265,491 | 296.4 K to 265.5 K (-10.44 %) |
| Mar 11 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 10,000 | 215,100 | 79,000 | |
| Mar 11 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.52 | 10,000 | 895,200 | 296,443 | 306.4 K to 296.4 K (-3.26 %) |
| Mar 11 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 10,000 | 215,100 | 306,443 | 296.4 K to 306.4 K (+3.37 %) |
| Mar 11 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | L | 94.39 | 30 | 2,832 | 296,443 | 296.4 K to 296.4 K (+0.01 %) |
| Mar 04 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 35,580 | 0 | 296,413 | 260.8 K to 296.4 K (+13.64 %) |
| Feb 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 10,000 | 215,100 | 89,000 | |
| Feb 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.50 | 10,000 | 835,000 | 328,530 | 338.5 K to 328.5 K (-2.95 %) |
| Feb 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 10,000 | 215,100 | 338,530 | 328.5 K to 338.5 K (+3.04 %) |
| Feb 03 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 1,000 | 21,510 | 99,000 | |
| Feb 03 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 1,000 | 21,510 | 328,530 | 327.5 K to 328.5 K (+0.31 %) |
| Jan 16 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 8,000 | 172,080 | 100,000 | |
| Jan 16 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.95 | 8,000 | 703,600 | 327,530 | 335.5 K to 327.5 K (-2.38 %) |
| Jan 16 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 8,000 | 172,080 | 335,530 | 327.5 K to 335.5 K (+2.44 %) |
| Jan 16 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 8,000 | 172,080 | 100,000 | |
| Jan 16 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.95 | 8,000 | 703,600 | 327,530 | 335.5 K to 327.5 K (-2.38 %) |
| Jan 16 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 8,000 | 172,080 | 335,530 | 327.5 K to 335.5 K (+2.44 %) |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 4,000 | 86,040 | 108,000 | |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 3,000 | 64,530 | 112,000 | |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.92 | 4,000 | 339,680 | 327,530 | 331.5 K to 327.5 K (-1.21 %) |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 4,000 | 86,040 | 331,530 | 327.5 K to 331.5 K (+1.22 %) |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 4,000 | 86,040 | 108,000 | |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.46 | 3,000 | 253,380 | 327,530 | 330.5 K to 327.5 K (-0.91 %) |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 3,000 | 64,530 | 112,000 | |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 3,000 | 64,530 | 330,530 | 327.5 K to 330.5 K (+0.92 %) |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.92 | 4,000 | 339,680 | 327,530 | 331.5 K to 327.5 K (-1.21 %) |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 4,000 | 86,040 | 331,530 | 327.5 K to 331.5 K (+1.22 %) |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.46 | 3,000 | 253,380 | 327,530 | 330.5 K to 327.5 K (-0.91 %) |
| Jan 09 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 3,000 | 64,530 | 330,530 | 327.5 K to 330.5 K (+0.92 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 5,000 | 107,550 | 115,000 | |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 3,000 | 64,530 | 120,000 | |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 630 | 0 | 180,261 | 180.9 K to 180.3 K (-0.35 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 86.16 | 5,000 | 430,800 | 327,530 | 332.5 K to 327.5 K (-1.50 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 5,000 | 107,550 | 332,530 | 327.5 K to 332.5 K (+1.53 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 86.43 | 3,000 | 259,290 | 327,530 | 330.5 K to 327.5 K (-0.91 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 3,000 | 64,530 | 330,530 | 327.5 K to 330.5 K (+0.92 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 5,000 | 107,550 | 115,000 | |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 3,000 | 64,530 | 120,000 | |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 630 | 0 | 180,261 | 180.9 K to 180.3 K (-0.35 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 86.16 | 5,000 | 430,800 | 327,530 | 332.5 K to 327.5 K (-1.50 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 5,000 | 107,550 | 332,530 | 327.5 K to 332.5 K (+1.53 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 86.43 | 3,000 | 259,290 | 327,530 | 330.5 K to 327.5 K (-0.91 %) |
| Dec 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 3,000 | 64,530 | 330,530 | 327.5 K to 330.5 K (+0.92 %) |
| Nov 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 4,000 | 86,040 | 123,000 | |
| Nov 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 6,000 | 129,060 | 127,000 | |
| Nov 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.60 | 10,000 | 776,000 | 327,080 | 337.1 K to 327.1 K (-2.97 %) |
| Nov 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 10,000 | 215,100 | 337,080 | 327.1 K to 337.1 K (+3.06 %) |
| Nov 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | L | 75.38 | 10 | 754 | 327,080 | 327.1 K to 327.1 K (0.00 %) |
| Nov 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 450 | 0 | 327,070 | 327.5 K to 327.1 K (-0.14 %) |
| Oct 29 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 5,000 | 107,550 | 133,000 | |
| Oct 29 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 69.55 | 5,000 | 347,750 | 327,520 | 332.5 K to 327.5 K (-1.50 %) |
| Oct 29 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 5,000 | 107,550 | 332,520 | 327.5 K to 332.5 K (+1.53 %) |
| Oct 02 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 74.23 | 219 | 16,256 | 7,274 | 7.1 K to 7.3 K (+3.10 %) |
| Oct 02 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 74.23 | 219 | 16,256 | 7,274 | 7.1 K to 7.3 K (+3.10 %) |